Unknown

Dataset Information

0

Potent and selective inhibitors of human reticulocyte 12/15-lipoxygenase as anti-stroke therapies.

ABSTRACT: A key challenge facing drug discovery today is variability of the drug target between species, such as with 12/15-lipoxygenase (12/15-LOX), which contributes to ischemic brain injury, but its human and rodent isozymes have different inhibitor specificities. In the current work, we have utilized a quantitative high-throughput (qHTS) screen to identify compound 1 (ML351), a novel chemotype for 12/15-LOX inhibition that has nanomolar potency (IC50 = 200 nM) against human 12/15-LOX and is protective against oxidative glutamate toxicity in mouse neuronal HT22 cells. In addition, it exhibited greater than 250-fold selectivity versus related LOX isozymes, was a mixed inhibitor, and did not reduce the active-site ferric ion. Lastly, 1 significantly reduced infarct size following permanent focal ischemia in a mouse model of ischemic stroke. As such, this represents the first report of a selective inhibitor of human 12/15-LOX with demonstrated in vivo activity in proof-of-concept mouse models of stroke.

SUBMITTER: Rai G 

PROVIDER: S-EPMC4033661 | biostudies-literature | 2014 May

REPOSITORIES: biostudies-literature

Json Xml
altmetric image

Publications

A key challenge facing drug discovery today is variability of the drug target between species, such as with 12/15-lipoxygenase (12/15-LOX), which contributes to ischemic brain injury, but its human and rodent isozymes have different inhibitor specificities. In the current work, we have utilized a quantitative high-throughput (qHTS) screen to identify compound 1 (ML351), a novel chemotype for 12/15-LOX inhibition that has nanomolar potency (IC50 = 200 nM) against human 12/15-LOX and is protective  ...[more]

Similar Datasets

Unknown Discovery of potent and selective inhibitors of human reticulocyte 15-lipoxygenase-1.
| S-EPMC2966298 | biostudies-literature
Unknown Discovery of potent and selective inhibitors of human platelet-type 12- lipoxygenase.
| S-EPMC3150642 | biostudies-literature
Unknown A high throughput screen identifies potent and selective inhibitors to human epithelial 15-lipoxygenase-2.
| S-EPMC4128814 | biostudies-literature
Unknown 5 S,15 S-Dihydroperoxyeicosatetraenoic Acid (5,15-diHpETE) as a Lipoxin Intermediate: Reactivity and Kinetics with Human Leukocyte 5-Lipoxygenase, Platelet 12-Lipoxygenase, and Reticulocyte 15-Lipoxygenase-1.
| S-EPMC7270142 | biostudies-literature
Unknown Inhibition of 12/15-lipoxygenase as therapeutic strategy to treat stroke.
| S-EPMC3563836 | biostudies-literature
Unknown Calcium promotes membrane association of reticulocyte 15-lipoxygenase.
| S-EPMC1137950 | biostudies-other
Unknown DDX6 recruits translational silenced human reticulocyte 15-lipoxygenase mRNA to RNP granules.
| S-EPMC2957058 | biostudies-literature
Unknown 12/15-Lipoxygenase Inhibition or Knockout Reduces Warfarin-Associated Hemorrhagic Transformation After Experimental Stroke.
| S-EPMC5263178 | biostudies-literature
Unknown A potent and selective inhibitor targeting human and murine 12/15-LOX.
| S-EPMC4778748 | biostudies-literature
Unknown Synthesis and structure-activity relationship studies of 4-((2-hydroxy-3-methoxybenzyl)amino)benzenesulfonamide derivatives as potent and selective inhibitors of 12-lipoxygenase.
| S-EPMC3967794 | biostudies-literature